Why I think Challenger Ltd is the best finance share

Challenger Ltd (ASX:CGF) is the best finance stock on the ASX in my opinion.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are many different types of finance stocks on the ASX. Banks such as Commonwealth Bank of Australia (ASX: CBA), fund managers like Magellan Financial Group Ltd (ASX: MFG) and diversified businesses like Macquarie Group Ltd (ASX: MQG) are all good options.

However, I think Challenger Ltd (ASX: CGF) is the best finance stock of all. Challenger is the leading annuity provider of Australia. Here are some reasons why I think it's a really good choice:

Generates strong funds under management

Challenger sells billions of dollars of annuities every year. Funds management isn't Challenger's main focus but it generates significant funds every year.

In FY17 the net flow of funds to Challenger was $6.2 billion and it had an average of $61.8 billion of funds under management during the year. This resulted in management fee earnings before interest and tax of $45 million, which is a decent percentage of the total earnings.

Long-term growth potential

Challenger has clear long-term tailwinds behind it.

Retirees are the biggest clients for taking up annuities because they are looking for guaranteed income for their capital.

The number of over-65s is expected to grow by 75% over the next two decades. I can't think of any other finance business that has such a clear growth trajectory.

Sustainable growth

There is a lot that could go wrong for Challenger in the short-term and the long-term, but I think Challenger is playing it safe by having a low dividend payout ratio of 50% of normalised net profit after tax.

Challenger also has a lot more capital than is required by regulatory capital. It had more than 1.5x the prescribed capital amount at the end of the financial year.

Foolish takeaway

Challenger is currently trading at 18x FY18's estimated earnings with a grossed-up dividend yield of 4.03%. I'd be a long-term buyer at the current price, but I'm holding out for a price in the low $11s or in the $10s before I buy again.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »